Regulatory Issues

Breakthrough Cystic Fibrosis Treatment on the Horizon

June 7, 2019

Elated. Nervous. Hopeful. That’s how thousands of cystic fibrosis patients felt upon hearing last week’s news: the Food and Drug Administration will soon review a new triple combination therapy that could drastically improve their quality of life.

Congressional Diabetes Caucus Confronts Insulin Affordability

November 14, 2018

A new white paper from the Congressional Diabetes Caucus reinforces what patients and advocates know all too well — the insulin pricing system is too complicated, the negotiations are too secretive and the cost for patients is too high.